R 0003/23 (Petition for review) of 19.05.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:R000323.20250519
- Date of decision
- 19 May 2025
- Case number
- R 0003/23
- Petition for review of
- -
- Application number
- 08853236.1
- IPC class
- A61K 31/381C07D 333/20A61P 25/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- POLYMORPHIC FORM OF ROTIGOTINE
- Applicant name
- UCB Pharma GmbH
- Opponent name
- Interquim, S.A.
Hexal AG
Generics [UK] Limited
Luye Pharma AG
Wittkopp, Alexander
AMW GmbH - Board
- -
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112a(2)(c)European Patent Convention Art 113(1)European Patent Convention R 106European Patent Convention R 109(2)(a)Rules of procedure of the Enlarged Board of Appeal Art 13Rules of procedure of the Enlarged Board of Appeal Art 14(2)
- Keywords
- Right to be heard Infringed (no)
Opportunity to comment
Petition for review rejected as clearly unallowable - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The petition for review is unanimously rejected as clearly unallowable.